Arrowhead Pharmaceuticals Inc.

In News

Arrowhead Pharmaceuticals: A True Inflection Point Has Arrived (NASDAQ:ARWR) - Seeking Alpha

Seeking Alpha - May 12, 2026

[144] ARROWHEAD PHARMACEUTICALS, INC. SEC Filing - Stock Titan

Stock Titan - May 12, 2026

Arrowhead Pharmaceuticals Reports Fiscal 2026 Second Quarter Results - Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc. - May 07, 2026

Arrowhead Pharmaceuticals Licenses Clinical MASH Program Targeting PNPLA3 to Madrigal Pharmaceuticals - Business Wire

Business Wire - May 05, 2026

Earnings call transcript: Arrowhead Pharma Q2 2026 beats EPS forecast - Investing.com

Investing.com - May 08, 2026

Arrowhead Pharmaceuticals Receives TGA Approval of REDEMPLO® (plozasiran) in Australia, Expanding Global Access for Patients with Familial Chylomicronemia Syndrome (FCS) - Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc. - May 01, 2026

Arrowhead Pharmaceuticals Inc. (ARWR): Billionaire Ken Fisher Bets Big on Pharma - Yahoo Finance

Yahoo Finance - Mar 17, 2026

Arrowhead (NASDAQ: ARWR) swings to loss as REDEMPLO launch and big financings reshape outlook - Stock Titan

Stock Titan - May 07, 2026

Arrowhead Pharmaceuticals Receives Positive CHMP Opinion Recommending Approval of REDEMPLO® (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS) in Europe - Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc. - Apr 24, 2026

Arrowhead Pharmaceuticals (NASDAQ: ARWR) posts Q2 2026 loss as prior milestone revenue fades - Stock Titan

Stock Titan - May 07, 2026

Arrowhead Pharmaceuticals to Webcast Fiscal 2026 Second Quarter Results - Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc. - Apr 20, 2026

Arrowhead Pharmaceuticals to Participate in Upcoming March 2026 Events - Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc. - Feb 24, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment